Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma. [electronic resource]
Producer: 20171222Description: 1855-60 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Aged, 80 and over
- Aurora Kinase A -- antagonists & inhibitors
- Azepines -- administration & dosage
- Disease-Free Survival
- Drug-Related Side Effects and Adverse Reactions -- pathology
- Female
- Humans
- Leiomyosarcoma -- drug therapy
- Liposarcoma -- drug therapy
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- administration & dosage
- Pyrimidines -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.